Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immucillin DI4G in Cutaneous Leishmaniasis
NCT03294161Phase 2Completed
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Start
- Dec 2014
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Immucillin DI4G in cutaneous leishmaniasis (CL), sponsored by Hospital Universitário Professor Edgard Santos. Started Dec 2014; status: completed.
02
Drugs
Immucillin DI4G
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT03294161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03294161.